NewsRadio WFLA (WFLA-AM)

American Medicine Today - Radio

American Medicine Today (AMT) - Kimberly Bonati, Ethan Youker & Spine surgeon Alfred Bonati, M.D. (innovation, medicine & politics)

  • 9/27/25 S11 E4575: DR. BRIT MOLLENHAUER - BLOOD TEST FOR PARKINSON'S DISEASE

9/27/25 S11 E4575: DR. BRIT MOLLENHAUER - BLOOD TEST FOR PARKINSON'S DISEASE

Saturday 27th September 2025

Explore the potential of a blood test to predict Parkinson's disease years before symptoms appear with Dr. Brit Mollenhauer.
Explicit
10 minutes
Informative
Hopeful
Inspiring
Educational
Encouraging

About this podcast

American Medicine Today - Radio
Author:
NewsRadio WFLA (WFLA-AM)
Overview:
Categories:
Innovative Treatments & Recovery Paths
Holistic Health Innovations
Innovative Healing Arts
Sexual Stigmas & Myths
Mindful Recovery
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Revolutionising Parkinson's Detection: A Blood Test Breakthrough

Episode Overview

  • A new blood test may predict Parkinson's disease up to seven years before symptoms appear.
  • Parkinson's disease involves a dopamine deficit due to protein aggregation.
  • Genetic and environmental factors contribute to Parkinson's risk.
  • Early detection could lead to more effective treatments.
  • Global collaboration is key in advancing Parkinson's research.
"We think that at that time, a causative treatment stopping this from progressing further might just be too late."
What if you could predict Parkinson's disease years before symptoms even begin? In this captivating episode of American Medicine Today, hosts Kimberly Bonatti and Ethan Uecker welcome Dr. Brit Mollenhauer, a neurologist from the University Medical Center in Göttingen, Germany. They explore groundbreaking research that could change how we understand and treat Parkinson's disease.
The discussion centres around a new blood test that can potentially identify the disease up to seven years before the onset of typical motor symptoms like tremors and stiffness. Dr. Mollenhauer sheds light on the complexities of Parkinson's, explaining how factors such as genetics, environmental influences, and lifestyle choices might contribute to its development. She also delves into the critical role dopamine plays in the brain and how its deficit leads to the disease's debilitating symptoms.
With a touch of humour and deep expertise, Dr. Mollenhauer explains why early detection is crucial and how this new test could pave the way for more effective treatments. The episode takes listeners on a journey through the scientific advancements and challenges in diagnosing and treating Parkinson's. It highlights the importance of continued research and collaboration across the globe to bring these innovations to a wider population.
For anyone interested in medical breakthroughs or affected by Parkinson's, this episode offers a mix of hope, information, and inspiration. Are we on the brink of a revolution in early disease detection? Tune in to find out.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.